GO Term | Evidence Code | PMID |
---|---|---|
testosterone biosynthetic process | ||
male genitalia development |
|
|
steroid biosynthetic process | ||
androgen biosynthetic process |
|
GO Term | Evidence Code | PMID |
---|---|---|
intracellular membrane-bounded organelle |
|
|
endoplasmic reticulum | ||
endoplasmic reticulum membrane |
|
GO Term | Evidence Code | PMID |
---|---|---|
estradiol 17-beta-dehydrogenase [NAD(P)] activity | ||
testosterone dehydrogenase [NAD(P)] activity |
|
|
protein binding | ||
17-beta-hydroxysteroid dehydrogenase (NADP+) activity | ||
testosterone 17-beta-dehydrogenase (NADP+) activity |
DO ID | Disease Name | Source |
---|---|---|
DOID:0112248 | 17-beta hydroxysteroid dehydrogenase 3 deficiency | |
DOID:10652 | Alzheimer's disease | |
DOID:1923 | disorder of sexual development | |
DOID:9352 | type 2 diabetes mellitus | |
DOID:9970 | obesity |
HPO ID | HPO Term |
---|---|
HP:0008730 | Female external genitalia in individual with 46,XY karyotype |
Disease ID | Disease Name |
---|---|
OMIM:264300 |
|
ORPHA:752 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.1.1
Last updated: February 17, 2025